Amino acid analysis can estimate how much peptide is present by measuring amino acids released when the chain is hydrolysed. The calculation uses the known sequence: each peptide molecule should contribute a defined number of each selected residue. Its reliability depends on both the amino-acid measurement and the assumptions connecting those amino acids to the intended peptide.
Separate the measured building blocks from the inferred chain
NIST's method chapter describes isotope-dilution LC-MS/MS measurement of amino acids for assigning protein and peptide concentrations. Calibrated amino-acid amounts provide a route back to the starting material when its composition is known. This quantitative use does not preserve the sequence order that existed before hydrolysis.Bunk and Lowenthal — Isotope-dilution LC-MS/MS amino acid analysis (opens in a new tab)
A measurement of alanine, for example, answers how much alanine the selected procedure detects. To infer peptide amount, the analyst also needs to know how many alanine residues the target contains and whether all relevant alanine originated from that target.
| Stage | Information needed |
|---|---|
| Release amino acids | Hydrolysis suitable for the intended peptide and selected residues |
| Measure amino-acid amount | Calibrators, response and appropriate correction |
| Infer peptide amount | Residue count, sample basis and interference assessment |
Divide by the number of residues per molecule
In an original example, imagine a peptide containing two alanine residues and one phenylalanine residue. Suppose the corrected measurements from the same sample portion give 20 nmol alanine and 10 nmol phenylalanine. The alanine estimate is 20 divided by 2, or 10 nmol peptide; the phenylalanine estimate is 10 divided by 1, also 10 nmol.
Adding the amino-acid amounts to report 30 nmol peptide would be wrong: the measured building blocks are counted several times per chain. Agreement between properly normalised residue estimates is more meaningful than their uncorrected numerical similarity.
If phenylalanine instead suggested 8 nmol peptide, the discrepancy would deserve explanation. Possible questions include recovery, interference and the assumed composition. Averaging incompatible estimates without investigating their difference can hide an analytical problem.
Converting the inferred amount to mass then requires the molecular form and molar mass appropriate to the reported peptide quantity. That is a separate step from dividing by residue count, and it should remain visible in the calculation record.
Check that release and survival are adequate
Bunk and Lowenthal explicitly identify incomplete hydrolysis and amino-acid degradation as limitations. Their approach selects amino acids stable under the conditions used and calls for hydrolysis validation for each protein or peptide. A precisely measured surviving fraction is not automatically the full amount originally present.Bunk and Lowenthal — Isotope-dilution LC-MS/MS amino acid analysis (opens in a new tab)
For an unfamiliar modification or unusual residue, ask whether the selected measurement still represents the intended composition. A method name copied from another peptide does not resolve the chemistry of the new material.
Account for other sources of the same amino acids
Melanson and colleagues' angiotensin II reference-material study corrected amino-acid-analysis results for related peptide impurities. This illustrates a central limitation: hydrolysis can erase the distinction between the target and another peptide that contributes the same measured building blocks.Melanson and colleagues — Peptide purity assignment using qNMR and amino acid analysis (opens in a new tab)
Free amino acids already present can create a similar attribution question. The reported measurand should state whether the result estimates the intended intact peptide after suitable corrections or a broader amino-acid-derived quantity.
A useful analytical account identifies the selected residues, individual normalised estimates, treatment of interfering material and final calculation basis. It connects a credible building-block measurement to a defensible peptide amount without presenting amino acid analysis as a complete sequence-identification test.
Sources and further detail
- Bunk and Lowenthal — Isotope-dilution LC-MS/MS amino acid analysis (opens in a new tab)
NIST-authored methods chapter (2019), DOI 10.1007/978-1-4939-9639-1_12. Quantification framework and hydrolysis limitations; no laboratory procedure reproduced.
- Melanson and colleagues — Peptide purity assignment using qNMR and amino acid analysis (opens in a new tab)
Anal Bioanal Chem 410, 6719–6731 (2018), DOI 10.1007/s00216-018-1272-7. Primary angiotensin II reference-material study; related-peptide interference is not assumed absent.
Sources checked 19 September 2026. Worked examples are illustrative unless a supplied report is explicitly identified. This article has not undergone independent scientific peer review.